On the use of immunomodulator rimantadine in acquired toxoplasmosis in children
The problem of toxoplasmosis in children is becoming increasingly important due to the fact that the infection without timely diagnosis and treatment, leads to their disability. The study examined the immune status in 35 children aged 3 to 14 years with chronic toxoplasmosis, as well as the possibility of immune immunomodulator "Remantadin".